<DOC>
	<DOCNO>NCT00375245</DOCNO>
	<brief_summary>The purpose study determine high safe dose rapamycin give fixed amount grapefruit juice .</brief_summary>
	<brief_title>Rapamycin With Grapefruit Juice Advanced Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Histologically confirm malignancy metastatic unresectable standard curative palliative measure exist longer effective . Patients hematologic malignancy ( lymphoma , multiple myeloma chronic lymphocytic leukemia ( CLL ) ) eligible participate phase IB portion trial . At least 4 week since prior chemotherapy radiation therapy Aged 18 year old ECOG performance status 02 Life expectancy great 3 month . Normal organ marrow function : No transfusion pack red blood cell within 1 week start treatment Leukocytes great equal 3,000/μL ** White blood cell ( WBC ) great equal 1,500/μL patient hematologic malignancy Absolute neutrophil count ( ANC ) great equal 1,500/μL ** ANC great equal 1,000/μL patient hematologic malignancy Platelets ( PLT ) great equal 100,000/μL ** PLT great equal 50,000/μL patient hematologic malignancy Total bilirubin within normal institutional limit AST ( SGOT ) ALT ( SGPT ) less equal 2.5 time institutional upper limit normal Serum triglyceride less equal 500 mg/dl Creatinine within normal institutional limit OR creatinine clearance great equal 60 mL/min patient creatinine level institutional normal Women childbearing potential men must agree use adequate contraception ( hormonal barrier method birth control ; abstinence ) Ability understand willingness sign write informed consent document . Chemotherapy radiotherapy within 4 week ( 6 week nitrosoureas mitomycin C ) prior enter study recover adverse event due agent administer 4 week earlier . May receive investigational agent . Uncontrolled brain metastasis malignancy . Can receive enzymeinducing anticonvulsant . History allergic reaction attribute compound similar chemical biologic composition rapamycin Gastrointestinal malabsorption syndrome , partial small bowel obstruction , illness would interfere ability absorb oral medication . Uncontrolled intercurrent illness Severe immunodeficient state ( judge treat physician ) Pregnant woman exclude study ; breastfeed discontinue . HIVpositive patient receive combination antiretroviral therapy exclude . Concurrent use ketoconazole , cyclosporine , tacrolimus , diltiazem , rifampin rapamycin permissible . The concurrent use calcium channel blocker , terfenadine , astemizole , cisapride , propafenone , cyclosporine , midazolam , triazolam , quinidine , theophylline grapefruit juice permissible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>phase I</keyword>
	<keyword>metastatic</keyword>
	<keyword>advanced cancer</keyword>
	<keyword>lung cancer</keyword>
	<keyword>renal cancer</keyword>
	<keyword>kidney cancer</keyword>
	<keyword>head neck cancer</keyword>
	<keyword>bladder cancer</keyword>
	<keyword>breast cancer</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>esophagus</keyword>
	<keyword>GIST</keyword>
	<keyword>liver cancer</keyword>
	<keyword>melanoma</keyword>
	<keyword>mesothelioma</keyword>
	<keyword>lymphoma</keyword>
	<keyword>ovary cancer</keyword>
	<keyword>ovarian cancer</keyword>
	<keyword>pancreas cancer</keyword>
	<keyword>pancreatic cancer</keyword>
	<keyword>prostate cancer</keyword>
	<keyword>stomach cancer</keyword>
	<keyword>thyroid cancer</keyword>
	<keyword>Metastatic solid tumor</keyword>
</DOC>